Showing results (41-50 of 158) with videos related to
Sort By:
Pageof 16
Renal Failure|August 26, 1998
Multiple myeloma and renal failure: one center's experienceC Magee, J P Vella, W P Tormey, et al.Human Immunology|December 1, 1989
Mixed lymphocyte response-generated suppressor cell specificity in humans is major histocompatibility complex-restrictedM H Sayegh, L A Turka, E L Milford, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2007
New insights in CD28-independent allograft rejectionA Habicht, N Najafian, H Yagita, et al.The American Journal of Pathology|June 1, 1994
Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity responseW W Hancock, S J Khoury, C B Carpenter, et al.Transplantation|January 9, 1998
Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allograftsT Glysing-Jensen, A Räisänen-Sokolowski, M H Sayegh, et al.The American Journal of Medicine|July 1, 1996
Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study GroupG M Chertow, M H Sayegh, R L Allgren, et al.The Journal of Clinical Investigation|September 1, 1997
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injuryM Takada, A Chandraker, K C Nadeau, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Rejection of mouse cardiac allografts by costimulation in transD A Mandelbrot, K Kishimoto, H Auchincloss, et al.Transplantation|July 15, 1997
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejectionB Murphy, K S Kim, R Buelow, et al.The Journal of Experimental Medicine|November 1, 1994
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptidesG Remuzzi, M Noris, A Benigni, et al.Pageof 16